DLBCL

>

Latest News

CAR T-Cell Therapy Presents a Paradigm Changing Option in DLBCL
CAR T-Cell Therapy Presents a Paradigm Changing Option in DLBCL

May 23rd 2024

During a Case-Based Roundtable® event, Sairah Ahmed, MD, discussed how the burgeoning use of chimeric antigen receptor T-cell therapy presents a paradigm shift in treatment for patients with diffuse large B-cell lymphoma in the first article of a 2-part series.

Alencar Discusses Treatment Choices After Early Relapse of DLBCL
Alencar Discusses Treatment Choices After Early Relapse of DLBCL

May 18th 2024

April Roundtable Roundup: B-cell Lymphoma
April Roundtable Roundup: B-cell Lymphoma

April 22nd 2024

Peers Discuss Role of Pola-R-CHP vs R-CHOP in Newly Diagnosed DLBCL
Peers Discuss Role of Pola-R-CHP vs R-CHOP in Newly Diagnosed DLBCL

April 19th 2024

Challenges for Non–CAR T-Cell Treatment of Early Relapsed DLBCL
Challenges for Non–CAR T-Cell Treatment of Early Relapsed DLBCL

April 18th 2024

Video Series
Video Interviews
Podcasts

More News